Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
salutaridine + NAD(P)H + H+
(7S)-salutaridinol + NAD(P)+
Substrates: NADPH is the highly preferred cofactor, the enzyme shows high substrate specificity, no activity with tropinone, (2)-menthone, codeinone and dehydroreticulinium ion, or nordehydroreticuline. Asp152, Ser180, Tyr236, and Lys240 are involved in the proton transfer system for the reduction of salutaridine, substrate-active site binding structure, overview
Products: the enzyme produces only the (7S)-salutaridinol stereoisomer as product, not the stereoisomer 7-epi-salutaridinol
r
salutaridine + NADH + H+
salutaridinol + NAD+
Substrates: -
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
salutaridine + NADPH + H+
salutaridinol + NADP+
salutaridinol + NADP+
salutaridine + NADPH + H+
Substrates: -
Products: -
?
additional information
?
-
salutaridine + NADPH + H+

(7S)-salutaridinol + NADP+
Papaver arenarium
-
Substrates: moderate levels of SalR expression in Papaver arenarium
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: -
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: moderate levels of SalR expression in Papaver bracteatum
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
-
Substrates: r
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: a step in the unique biosynthesis of morphine via codeine, overview
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: NADPH-dependent reduction of the 7-keto group
Products: no formation of 7-epi-salutaridinol
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: -
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
-
Substrates: high levels of SalR expression in all Papaver somniferum varieties
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
-
Substrates: interaction between SalR and SalAT in morphine biosynthesis
Products: -
?
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: a step in the unique biosynthesis of morphine via codeine, overview
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: NADPH-dependent reduction of the 7-keto group
Products: no formation of 7-epi-salutaridinol
r
salutaridine + NADPH + H+

salutaridinol + NADP+
-
Substrates: formation of salutaridinol, a precursor for the synthesis of morphine and related opium alkaloids
Products: -
?
salutaridine + NADPH + H+
salutaridinol + NADP+
Substrates: -
Products: -
r
salutaridine + NADPH + H+
salutaridinol + NADP+
-
Substrates: -
Products: -
r
additional information

?
-
Substrates: the enzyme is involved in the biosynthesis of morphine
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in the biosynthesis of morphine
Products: -
?
additional information
?
-
Substrates: interaction of benzylisoquinoline alkaloids with enzymes, modeling, overview
Products: -
?
additional information
?
-
-
Substrates: interaction of benzylisoquinoline alkaloids with enzymes, modeling, overview
Products: -
?
additional information
?
-
-
Substrates: occurrence of active SalR homologue in Papaver pilosum, although it does not produce salutaridine or any other promorphinan alkaloid
Products: -
?
additional information
?
-
Papaver pyrenaicum
-
Substrates: occurrence of active SalR homologue in Papaver pyrenaicum, although it does not produce salutaridine or any other promorphinan alkaloid
Products: -
?
additional information
?
-
Substrates: alkaloid composition of the organism
Products: -
?
additional information
?
-
-
Substrates: alkaloid composition of the organism
Products: -
?
additional information
?
-
Substrates: no reduction of 1,2-nordehydroreticuline, 1,2-dehydroreticulinium ion, codeinone, tropinone, or (-)-menthone, no oxidation of (R)-norreticuline, (R)-reticuline, codeine, tropine, or (+)-neomenthol
Products: -
?
additional information
?
-
-
Substrates: no reduction of 1,2-nordehydroreticuline, 1,2-dehydroreticulinium ion, codeinone, tropinone, or (-)-menthone, no oxidation of (R)-norreticuline, (R)-reticuline, codeine, tropine, or (+)-neomenthol
Products: -
?
additional information
?
-
Substrates: alkaloid composition of the organism
Products: -
?
additional information
?
-
Substrates: no reduction of 1,2-nordehydroreticuline, 1,2-dehydroreticulinium ion, codeinone, tropinone, or (-)-menthone, no oxidation of (R)-norreticuline, (R)-reticuline, codeine, tropine, or (+)-neomenthol
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
salutaridine + NADPH + H+
salutaridinol + NADP+
additional information
?
-
salutaridine + NADPH + H+

(7S)-salutaridinol + NADP+
Substrates: -
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: a step in the unique biosynthesis of morphine via codeine, overview
Products: -
r
salutaridine + NADPH + H+
(7S)-salutaridinol + NADP+
Substrates: a step in the unique biosynthesis of morphine via codeine, overview
Products: -
r
salutaridine + NADPH + H+

salutaridinol + NADP+
-
Substrates: formation of salutaridinol, a precursor for the synthesis of morphine and related opium alkaloids
Products: -
?
salutaridine + NADPH + H+
salutaridinol + NADP+
Substrates: -
Products: -
r
salutaridine + NADPH + H+
salutaridinol + NADP+
-
Substrates: -
Products: -
r
additional information

?
-
Substrates: the enzyme is involved in the biosynthesis of morphine
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in the biosynthesis of morphine
Products: -
?
additional information
?
-
Substrates: alkaloid composition of the organism
Products: -
?
additional information
?
-
-
Substrates: alkaloid composition of the organism
Products: -
?
additional information
?
-
Substrates: alkaloid composition of the organism
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0015
(7S)-salutaridinol
pH 6.0, 40°C, recombinant enzyme
0.023
DNA with apurinic site
pH 9.5, 30°C, recombinant enzyme, oxidation reaction
-
1.19
NADH
pH 6.0, 40°C, recombinant enzyme, with salutaridine
0.0021 - 0.4086
salutaridine
additional information
additional information
-
0.007
NADP+

pH 6.0, 40°C, recombinant enzyme, with salutaridinol
0.198
NADP+
pH 9.5, 30°C, recombinant enzyme, oxidation reaction
0.0034
NADPH

mutant K186V
0.0035
NADPH
pH 6.0, 40°C, recombinant enzyme, with salutaridine
0.0045
NADPH
mutant S181A
0.0097
NADPH
mutant F104A
0.0155
NADPH
mutant L266A
0.0156
NADPH
mutant N272A
0.0198
NADPH
mutant M271A
0.0211
NADPH
mutant I275A
0.0213
NADPH
mutant T182A
0.0297
NADPH
mutant L185A
0.0305
NADPH
mutant D107A
0.043
NADPH
mutant F104A/I275A
0.08
NADPH
pH 6.0, 30°C, recombinant enzyme, reduction reaction
0.0021
salutaridine

wild-type
0.0041
salutaridine
mutant T182A
0.005
salutaridine
mutant S181A
0.0078
salutaridine
mutant K186V
0.0079
salutaridine
pH 6.0, 40°C, recombinant enzyme
0.0089
salutaridine
mutant V106A
0.0132
salutaridine
mutant L185A
0.0148
salutaridine
mutant D107A
0.0225
salutaridine
mutant M271A
0.031
salutaridine
pH 6.0, 30°C, recombinant enzyme, reduction reaction
0.0318
salutaridine
mutant F104A
0.0331
salutaridine
mutant I275A
0.0494
salutaridine
mutant L266A
0.0901
salutaridine
mutant N272A
0.4086
salutaridine
mutant F104A/I275A
additional information
additional information

kinetics, recombinant enzyme
-
additional information
additional information
-
kinetics, recombinant enzyme
-
additional information
additional information
kinetics of wild-type and mutant enzymes, overview
-
additional information
additional information
-
kinetics of wild-type and mutant enzymes, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
34050
1 * 36600, recombinant His-tagged enzyme, SDS-PAGE, 1 * 34050, sequence calculation, the tertiary structure comprises the typical short-chain dehydrogenase/reductase family alpha/beta folding pattern including the four additional helices alphaF-1 to alphaF-4 assumed to prevent the dimerization, modeling and analysis, overview
34100
1 * 34100, sequence calculation, 1 * 40000, recombinant His6-tagged enzyme, SDS-PAGE
36600
1 * 36600, recombinant His-tagged enzyme, SDS-PAGE, 1 * 34050, sequence calculation, the tertiary structure comprises the typical short-chain dehydrogenase/reductase family alpha/beta folding pattern including the four additional helices alphaF-1 to alphaF-4 assumed to prevent the dimerization, modeling and analysis, overview
40000
1 * 34100, sequence calculation, 1 * 40000, recombinant His6-tagged enzyme, SDS-PAGE
47100 - 50100
recombinant enzyme, gel filtration
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
F104A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
K240E
site-directed mutagenesis, inactive mutant
L266A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
L266S
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
L266V
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
M271T
site-directed mutagenesis, inactive mutant
N152A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
N272T
site-directed mutagenesis, inactive mutant
R44E
site-directed mutagenesis, the mutant enzyme shows altered cofactor specificity and utilizes also NADH in contrast to the wild-type enzyme
R48E
site-directed mutagenesis, the mutant enzyme shows altered cofactor specificity and utilizes also NADH in contrast to the wild-type enzyme
S180A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
V106A
site-directed mutagenesis, the mutant shows about 2fold increased activity compared to the wild-type enzyme
Y236F
site-directed mutagenesis, inactive mutant
I275V
the mutant shows altered kinetics compared to the wild-type enzyme
L185S
the mutant shows altered kinetics compared to the wild-type enzyme
L185V
the mutant shows altered kinetics compared to the wild-type enzyme
additional information
-
specific virus-induced gene silencing as a functional genomics tool to investigate the regulation of morphine biosynthesis via a systematic reduction in enzyme levels responsible for the final six steps in the pathway, overview. Reduced SalR protein levels correlate with lower morphine levels and a substantial increase in the accumulation of salutaridine
D107A

increase in Km, 2fold decrease in kcat
D107A
the mutant shows altered kinetics compared to the wild-type enzyme
F104A

increase in kcat
F104A
the mutant shows altered kinetics compared to the wild-type enzyme
F104A/I275A

shows no substrate inhibition accompanied by a weak affinity for productive salutaridine binding, kcat is almost 2fold higher compared with the wild-type
F104A/I275A
substitution of Phe104 in the substrate-binding pocket, and Ile275 under the flap domain, the mutant shows altered kinetics compared to the wild-type enzyme
I275A

increase in Km, shows an increase of velocity by a factor of 2.3
I275A
the mutant shows altered kinetics compared to the wild-type enzyme
K186V

moderate effects on substrate affinity, exhibits a turnover number similar to that of the wild-type
K186V
the mutant shows altered kinetics compared to the wild-type enzyme
L185A

increase in Km, decrease in kcat
L185A
the mutant shows altered kinetics compared to the wild-type enzyme
L266A

decrease in kcat
L266A
the mutant shows altered kinetics compared to the wild-type enzyme
M271A

increase in Km
M271A
the mutant shows altered kinetics compared to the wild-type enzyme
N272A

increase in Km, decrease in kcat
N272A
the mutant shows altered kinetics compared to the wild-type enzyme
S181A

moderate effects on substrate affinity, increase in kcat by 50%
S181A
the mutant shows altered kinetics compared to the wild-type enzyme
T182A

moderate effects on substrate affinity
T182A
the mutant shows altered kinetics compared to the wild-type enzyme
V106A

moderate effects on substrate affinity, increase in kcat by 90%
V106A
the mutant shows altered kinetics compared to the wild-type enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
cloned into the pMyr vector and expressed as fusion protein with a myristylation sequence, which anchors the target protein to the yeast membrane. Fusion proteins (pSOS/SalAT and pMyr/SalR) coexpressed in the Saccharomyces cerevisiae cdc25H strain. SalR amplified from the recombinant plasmid SalR/pQE-30. The 0.9-kb DNA fragment ligated into an NheI/EcoRI-digested pET28a expression vector. SalR/pET28a expression construct transformed into Escherichia coli BL21(DE3)RIL
-
expression in Escherichia coli
gene salR, DNA and amino acid sequence determination and analysis, expression profile, overexpression in Escherichia coli strain SG13009 as His6-tagged enzyme
gene salR, expression of N-terminally His-tagged enzyme in Escherichia coli, a selenomethionine-substituted SalR is produced by inhibition of the methionine biosynthetic pathway with the same expression vector and Escherichia coli strain used for expression of wild-type SalR
heterologously overexpressed in its active form from Papaver somniferum
-
overexpression in Escherichia coli SG13009
real-time quantitative PCR expression analysis
-
salR, DNA and amino acid sequence determination and analysis, overexpression of the His-tagged enzyme in Escherichia coli
salutaridine synthase (PsSAS), salutaridine reductase (PsSAR) and salutaridinol acetyltransferase (PsSAT) are functionally coexpressed in Saccharomyces cerevisiae and optimization of the pH conditions allowed for productive spontaneous rearrangement of salutaridinol-7-O-acetate and synthesis of thebaine from (R)-reticuline. A 7-gene pathway for the production of codeine and morphine from (R)-reticuline is reconstituted. Yeast cell feeding assays using (R)-reticuline, salutaridine or codeine as substrates show that all enzymes are functionally coexpressed in yeast and that activity of salutaridine reductase and codeine-O-demethylase likely limit flux to morphine synthesis. The results of this study describe a significant advance for the synthesis of morphinans in Saccharomyces cerevisiae and pave the way for their complete synthesis in recombinant microbes
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Gerardy, R.; Zenk, M.H.
Purification and characterization of salutaridine:NADPH 7-oxidoreductase from Papaver somniferum
Phytochemistry
34
125-132
1993
no activity in Papaver alpinum, no activity in Papaver atlanticum, no activity in Papaver dubium, no activity in Papaver feddei, no activity in Papaver lateritium, no activity in Papaver oreophilum, no activity in Papaver orientale, no activity in Papaver persicum, no activity in Papaver pilosum, no activity in Papaver rhoeas, no activity in Papaver rupifragum, no activity in Papaver strigosum, no activity in Papaver tauricula, no activity in Papaver triniifolium, Papaver bracteatum, Papaver somniferum
-
brenda
Ziegler, J.; Voigtlaender, S.; Schmidt, J.; Kramell, R.; Miersch, O.; Ammer, C.; Gesell, A.; Kutchan, T.M.
Comparative transcript and alkaloid profiling in Papaver species identifies a short chain dehydrogenase/reductase involved in morphine biosynthesis
Plant J.
48
177-192
2006
Papaver somniferum (Q071N0), Papaver somniferum, Papaver somniferum salR (Q071N0)
brenda
Geissler, R.; Brandt, W.; Ziegler, J.
Molecular modeling and site-directed mutagenesis reveal the benzylisoquinoline binding site of the short-chain dehydrogenase/reductase salutaridine reductase
Plant Physiol.
143
1493-1503
2007
Papaver bracteatum (A4UHT7), Papaver bracteatum
brenda
Ziegler, J.; Brandt, W.; Geissler, R.; Facchini, P.J.
Removal of substrate inhibition and increase in maximal velocity in the short chain dehydrogenase/reductase salutaridine reductase involved in morphine biosynthesis
J. Biol. Chem.
284
26758-26767
2009
Papaver somniferum (Q071N0)
brenda
Ziegler, J.; Facchini, P.J.; Geissler, R.; Schmidt, J.; Ammer, C.; Kramell, R.; Voigtlaender, S.; Gesell, A.; Pienkny, S.; Brandt, W.
Evolution of morphine biosynthesis in opium poppy
Phytochemistry
70
1696-1707
2009
Papaver arenarium, Papaver bracteatum (A4UHT7), Papaver pilosum, Papaver pyrenaicum, Papaver somniferum
brenda
Kempe, K.; Higashi, Y.; Frick, S.; Sabarna, K.; Kutchan, T.M.
RNAi suppression of the morphine biosynthetic gene salAT and evidence of association of pathway enzymes
Phytochemistry
70
579-589
2009
Papaver somniferum
brenda
Higashi, Y.; Smith, T.J.; Jez, J.M.; Kutchan, T.M.
Crystallization and preliminary X-ray diffraction analysis of salutaridine reductase from the opium poppy Papaver somniferum
Acta Crystallogr. Sect. F
66
163-166
2010
Papaver somniferum (Q071N0), Papaver somniferum
brenda
Wijekoon, C.P.; Facchini, P.J.
Systematic knockdown of morphine pathway enzymes in opium poppy using virus-induced gene silencing
Plant J.
69
1052-1063
2012
Papaver somniferum
brenda
Higashi, Y.; Kutchan, T.M.; Smith, T.J.
Atomic structure of salutaridine reductase from the opium poppy (Papaver somniferum)
J. Biol. Chem.
286
6532-6541
2011
Papaver somniferum (Q071N0), Papaver somniferum
brenda
Fossati, E.; Narcross, L.; Ekins, A.; Falgueyret, J.P.; Martin, V.J.
Synthesis of morphinan alkaloids in Saccharomyces cerevisiae
PLoS ONE
10
e0124459
2015
Papaver somniferum (Q071N0), Papaver somniferum
brenda